Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Middle East Pharmaceutical Industries Co Days Inventory?
Middle East Pharmaceutical Industries CoSAU:4016 -1.32%22 Days Inventory is 188.81 as of Mar. 2026, which is 14% below its 10-year median of 219.00. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Middle East Pharmaceutical Industries Co ranks worse than 63.19% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Middle East Pharmaceutical Industries Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.48.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Middle East Pharmaceutical Industries Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.79.
Middle East Pharmaceutical Industries Co (SAU:4016) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Middle East Pharmaceutical Industries Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Middle East Pharmaceutical Industries Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Middle East Pharmaceutical Industries Co Days Inventory Related Terms
Middle East Pharmaceutical Industries Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co Days Inventory Chart
Middle East Pharmaceutical Industries Co Annual Data
Trend
Dec23
Dec24
Dec25
Days Inventory
236.71
219.00
207.17
Middle East Pharmaceutical Industries Co Quarterly Data
SAU:4016 vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Pharmaceutical Industries Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co (SAU:4016) has a Days Inventory of 188.81 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Middle East Pharmaceutical Industries Co and its competitors. This is 14% below median its historical median of 219.00. Over the past decade, Middle East Pharmaceutical Industries Co's Days Inventory has ranged from 198.01 to 236.71. According to the industry distribution chart, Middle East Pharmaceutical Industries Co ranks #582 out of 921 companies in the Drug Manufacturers industry, placing it in the top 63.2%.
Is Middle East Pharmaceutical Industries Co's Days Inventory too high?
Middle East Pharmaceutical Industries Co's current Days Inventory of 188.81 is 14% below median its 10-year median of 219.00. Over the past 10 years, this metric has ranged from a low of 198.01 to a high of 236.71. The Drug Manufacturers industry median Days Inventory is 164.48. Middle East Pharmaceutical Industries Co's value of 188.81 is 14.8% above this industry median. Based on the distribution chart, Middle East Pharmaceutical Industries Co ranks #582 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Middle East Pharmaceutical Industries Co ranks #582 out of 921 companies for Days Inventory. This places Middle East Pharmaceutical Industries Co in the lower half of its industry. The industry median Days Inventory is 164.48. Middle East Pharmaceutical Industries Co's value of 188.81 is 14.8% above this benchmark. Historically, Middle East Pharmaceutical Industries Co's own Days Inventory has ranged from 198.01 to 236.71 over the past decade. While the company's 10-year median is 219.00 vs. the industry median of 164.48, Middle East Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Pharmaceutical Industries Co's current Days Inventory of 188.81 is 14.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Middle East Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Pharmaceutical Industries Co's current Days Inventory is 188.81, which is 14% below median its own 10-year median of 219.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Days Inventory of 188.81. The current Days Inventory is 188.81, which is 14% below median its 10-year median of 219.00 and 14.8% above the Drug Manufacturers industry median of 164.48. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Days Inventory is 188.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Middle East Pharmaceutical Industries Co Business Description
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score
Get the complete analysis for SAU:4016
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4016 has been successfully added to your 
